Microsoft Q3 Beat on Revenue & EPS, But Record Capex and Q4 Outlook Disappoint Investors
Microsoft beat earnings with strong cloud and AI growth, but high spending and a weak outlook disappointed investors; shares fell.
NOTRELOAD AI
Amazon Crushes Q1 Cloud Forecasts as AI Demand Fuels 28% AWS Jump
Amazon beat earnings/revenue forecasts; AWS AI demand surged. Stock rose after-hours despite weak cash flow outlook and high AI investment.
PayPal Makes Venmo a Standalone Unit as Buyers Circle
PayPal splits Venmo into own unit to boost clarity and value; restructures company, cuts complexity, shares rise on news.
Teradyne Stock Drops After Record AI-Powered Q1 — But Q2 Guidance Disappoints
Teradyne had record sales from AI chip demand, but cautious outlook for next quarter sent shares down despite strong results.
Teva Beats Q1 2026 Forecasts as AUSTEDO & UZEDY Surge — Acquires Emalex for $700M Tourette Drug
Teva buys Emalex for $700M to add a new Tourette drug. Strong sales growth led by key medicines; generics weaker but outlook solid.
Chiesi Buys KalVista for $1.9 Billion in Biggest Deal Yet to Strengthen Rare Disease Portfolio
Chiesi will buy KalVista for $1.9B to get EKTERLY, a new oral rare disease drug, and grow its global rare disease business.